Disambiguation evidence for Inmazeb (in combination with atoltivimab and odesivimab) via surface form

"Inmazeb (in combination with atoltivimab and odesivimab)"

Triples (1)

Triples where some other subject referred to this entity as "Inmazeb (in combination with atoltivimab and odesivimab)".

maftivimab → isMarketedAs →
"Inmazeb (in combination with atoltivimab and odesivimab)"
ⓘ